OCUL Annual CAPEX
$6.09 M
+$2.37 M+63.85%
31 December 2023
Summary:
As of January 23, 2025, OCUL annual capital expenditures is $6.09 million, with the most recent change of +$2.37 million (+63.85%) on December 31, 2023. During the last 3 years, it has risen by +$5.25 million (+623.78%). OCUL annual CAPEX is now -26.24% below its all-time high of $8.25 million, reached on December 31, 2017.OCUL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCUL Quarterly CAPEX
$89.00 K
-$653.00 K-88.01%
30 September 2024
Summary:
As of January 23, 2025, OCUL quarterly capital expenditures is $89.00 thousand, with the most recent change of -$653.00 thousand (-88.01%) on September 30, 2024. Over the past year, it has dropped by -$170.00 thousand (-65.64%). OCUL quarterly CAPEX is now -97.77% below its all-time high of $4.00 million, reached on June 30, 2017.OCUL Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCUL TTM CAPEX
$1.54 M
-$170.00 K-9.91%
30 September 2024
Summary:
As of January 23, 2025, OCUL TTM capital expenditures is $1.54 million, with the most recent change of -$170.00 thousand (-9.91%) on September 30, 2024. Over the past year, it has dropped by -$6.23 million (-80.14%). OCUL TTM CAPEX is now -81.54% below its all-time high of $8.37 million, reached on September 30, 2017.OCUL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCUL CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.9% | -65.6% | -80.1% |
| 3 y3 years | +623.8% | -67.8% | +89.3% |
| 5 y5 years | +222.2% | -78.8% | -31.0% |
OCUL CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +409.8% | -97.4% | at low | -81.4% | +29.4% |
| 5 y | 5-year | at high | +623.8% | -97.4% | at low | -81.4% | +106.0% |
| alltime | all time | -26.2% | +2898.5% | -97.8% | +17.1% | -81.5% | +420.2% |
Ocular Therapeutix CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $89.00 K(-88.0%) | $1.54 M(-9.9%) |
| June 2024 | - | $742.00 K(+191.0%) | $1.72 M(-42.1%) |
| Mar 2024 | - | $255.00 K(-44.4%) | $2.96 M(-51.3%) |
| Dec 2023 | $6.09 M(+63.8%) | $459.00 K(+77.2%) | $6.09 M(-21.7%) |
| Sept 2023 | - | $259.00 K(-87.0%) | $7.78 M(-6.4%) |
| June 2023 | - | $1.99 M(-41.1%) | $8.31 M(+21.9%) |
| Mar 2023 | - | $3.38 M(+57.2%) | $6.82 M(+83.5%) |
| Dec 2022 | $3.71 M(+211.1%) | $2.15 M(+170.8%) | $3.71 M(+69.2%) |
| Sept 2022 | - | $794.00 K(+60.4%) | $2.20 M(+30.9%) |
| June 2022 | - | $495.00 K(+79.3%) | $1.68 M(+27.9%) |
| Mar 2022 | - | $276.00 K(-56.3%) | $1.31 M(+9.9%) |
| Dec 2021 | $1.19 M(+42.0%) | $631.00 K(+128.6%) | $1.19 M(+46.3%) |
| Sept 2021 | - | $276.00 K(+114.0%) | $816.00 K(+8.2%) |
| June 2021 | - | $129.00 K(-18.4%) | $754.00 K(+0.5%) |
| Mar 2021 | - | $158.00 K(-37.5%) | $750.00 K(-10.8%) |
| Dec 2020 | $841.00 K(-62.4%) | $253.00 K(+18.2%) | $841.00 K(-29.3%) |
| Sept 2020 | - | $214.00 K(+71.2%) | $1.19 M(-14.7%) |
| June 2020 | - | $125.00 K(-49.8%) | $1.39 M(-20.9%) |
| Mar 2020 | - | $249.00 K(-58.6%) | $1.76 M(-21.3%) |
| Dec 2019 | $2.24 M | $601.00 K(+43.4%) | $2.24 M(+5.8%) |
| Sept 2019 | - | $419.00 K(-15.0%) | $2.12 M(-2.5%) |
| June 2019 | - | $493.00 K(-32.0%) | $2.17 M(-2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $725.00 K(+51.4%) | $2.23 M(+18.2%) |
| Dec 2018 | $1.89 M(-77.1%) | $479.00 K(+1.3%) | $1.89 M(-4.3%) |
| Sept 2018 | - | $473.00 K(-14.9%) | $1.97 M(-44.2%) |
| June 2018 | - | $556.00 K(+45.9%) | $3.54 M(-49.3%) |
| Mar 2018 | - | $381.00 K(-32.4%) | $6.98 M(-15.4%) |
| Dec 2017 | $8.25 M(+330.0%) | $564.00 K(-72.3%) | $8.25 M(-1.4%) |
| Sept 2017 | - | $2.04 M(-49.1%) | $8.37 M(+16.2%) |
| June 2017 | - | $4.00 M(+141.7%) | $7.20 M(+109.0%) |
| Mar 2017 | - | $1.65 M(+143.2%) | $3.45 M(+79.6%) |
| Dec 2016 | $1.92 M(+7.9%) | $680.00 K(-21.7%) | $1.92 M(+12.1%) |
| Sept 2016 | - | $869.00 K(+257.6%) | $1.71 M(+86.3%) |
| June 2016 | - | $243.00 K(+91.3%) | $919.00 K(-40.7%) |
| Mar 2016 | - | $127.00 K(-73.2%) | $1.55 M(-12.8%) |
| Dec 2015 | $1.78 M(+41.1%) | $473.00 K(+522.4%) | $1.78 M(+1.8%) |
| Sept 2015 | - | $76.00 K(-91.3%) | $1.75 M(-10.2%) |
| June 2015 | - | $875.00 K(+147.2%) | $1.94 M(+47.6%) |
| Mar 2015 | - | $354.00 K(-19.7%) | $1.32 M(+4.5%) |
| Dec 2014 | $1.26 M(+225.6%) | $441.00 K(+60.9%) | $1.26 M(+53.8%) |
| Sept 2014 | - | $274.00 K(+10.5%) | $819.00 K(+50.3%) |
| June 2014 | - | $248.00 K(-16.5%) | $545.00 K(+83.5%) |
| Mar 2014 | - | $297.00 K | $297.00 K |
| Dec 2013 | $387.00 K(+90.6%) | - | - |
| Dec 2012 | $203.00 K | - | - |
FAQ
- What is Ocular Therapeutix annual capital expenditures?
- What is the all time high annual CAPEX for Ocular Therapeutix?
- What is Ocular Therapeutix annual CAPEX year-on-year change?
- What is Ocular Therapeutix quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly CAPEX year-on-year change?
- What is Ocular Therapeutix TTM capital expenditures?
- What is the all time high TTM CAPEX for Ocular Therapeutix?
- What is Ocular Therapeutix TTM CAPEX year-on-year change?
What is Ocular Therapeutix annual capital expenditures?
The current annual CAPEX of OCUL is $6.09 M
What is the all time high annual CAPEX for Ocular Therapeutix?
Ocular Therapeutix all-time high annual capital expenditures is $8.25 M
What is Ocular Therapeutix annual CAPEX year-on-year change?
Over the past year, OCUL annual capital expenditures has changed by +$2.37 M (+63.85%)
What is Ocular Therapeutix quarterly capital expenditures?
The current quarterly CAPEX of OCUL is $89.00 K
What is the all time high quarterly CAPEX for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly capital expenditures is $4.00 M
What is Ocular Therapeutix quarterly CAPEX year-on-year change?
Over the past year, OCUL quarterly capital expenditures has changed by -$170.00 K (-65.64%)
What is Ocular Therapeutix TTM capital expenditures?
The current TTM CAPEX of OCUL is $1.54 M
What is the all time high TTM CAPEX for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM capital expenditures is $8.37 M
What is Ocular Therapeutix TTM CAPEX year-on-year change?
Over the past year, OCUL TTM capital expenditures has changed by -$6.23 M (-80.14%)